Zhuhai Trinomab Pharmaceutical Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 767

Employees

  • Stock Symbol
  • 688806

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $3.29
  • (As of Friday Closing)

Zhuhai Trinomab Pharmaceutical General Information

Description

Zhuhai Trinomab Pharmaceutical Co Ltd is a biopharmaceutical company engaged in the development, production and sales of fully human antibody drugs.

Contact Information

Website
www.trinomab.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 2F, Building 6C, Zhizao Street, Hongqi Town
  • Jinwan District
  • Zhuhai, Guangdong 519000
  • China
+86 0756
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
SHG
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 2F, Building 6C, Zhizao Street, Hongqi Town
  • Jinwan District
  • Zhuhai, Guangdong 519000
  • China
+86 0756

Zhuhai Trinomab Pharmaceutical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zhuhai Trinomab Pharmaceutical Stock Performance

As of 13-Nov-2026, Zhuhai Trinomab Pharmaceutical’s stock price is $3.29. Its current market cap is $1.52B with 461M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.29 $3.47 $2.96 - $7.75 $1.52B 461M 6.87M -$0.16

Zhuhai Trinomab Pharmaceutical Financials Summary

As of 30-Sep-2026, Zhuhai Trinomab Pharmaceutical has a trailing 12-month revenue of $25.4M.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,154,222
Revenue 25,442 7,123 2,098 0
EBITDA (63,306) (75,960) (65,303) (58,139)
Net Income (65,346) (83,617) (71,740) (63,105)
Total Assets 277,286 139,852 127,847 139,933
Total Debt 130,512 99,462 55,105 28,727
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Zhuhai Trinomab Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zhuhai Trinomab Pharmaceutical‘s full profile, request access.

Request a free trial

Zhuhai Trinomab Pharmaceutical Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Zhuhai Trinomab Pharmaceutical‘s full profile, request access.

Request a free trial

Zhuhai Trinomab Pharmaceutical Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Zhuhai Trinomab Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022127793-A1 Respiratory syncytial virus-specific binding molecule Inactive 18-Dec-2020

Zhuhai Trinomab Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zhuhai Trinomab Pharmaceutical Investments (1)

Zhuhai Trinomab Pharmaceutical’s most recent deal was a Joint Venture with Manufacturer of Medical Drugs (China Medical System / Trinomab). The deal was made on 26-Apr-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Manufacturer of Medical Drugs (China Medical System / Trinomab) 26-Apr-2021 Joint Venture Pharmaceuticals
To view Zhuhai Trinomab Pharmaceutical’s complete investments history, request access »

Zhuhai Trinomab Pharmaceutical FAQs

  • When was Zhuhai Trinomab Pharmaceutical founded?

    Zhuhai Trinomab Pharmaceutical was founded in 2015.

  • Where is Zhuhai Trinomab Pharmaceutical headquartered?

    Zhuhai Trinomab Pharmaceutical is headquartered in Zhuhai, China.

  • What is the size of Zhuhai Trinomab Pharmaceutical?

    Zhuhai Trinomab Pharmaceutical has 767 total employees.

  • What industry is Zhuhai Trinomab Pharmaceutical in?

    Zhuhai Trinomab Pharmaceutical’s primary industry is Drug Discovery.

  • Is Zhuhai Trinomab Pharmaceutical a private or public company?

    Zhuhai Trinomab Pharmaceutical is a Public company.

  • What is Zhuhai Trinomab Pharmaceutical’s stock symbol?

    The ticker symbol for Zhuhai Trinomab Pharmaceutical is 688806.

  • What is the current stock price of Zhuhai Trinomab Pharmaceutical?

    As of 13-Nov-2026 the stock price of Zhuhai Trinomab Pharmaceutical is $3.29.

  • What is the current market cap of Zhuhai Trinomab Pharmaceutical?

    The current market capitalization of Zhuhai Trinomab Pharmaceutical is $1.52B.

  • What is Zhuhai Trinomab Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Zhuhai Trinomab Pharmaceutical is $25.4M.

  • What is Zhuhai Trinomab Pharmaceutical’s annual earnings per share (EPS)?

    Zhuhai Trinomab Pharmaceutical’s EPS for 12 months was -$0.16.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process